Ved V. Topkar

6.4k citations

15 papers · 4.3k indexed · 4 hit papers · h-index 11

Business and International Management top 0.2%
Aging top 0.5%
Molecular Biology top 1%
- CRISPR and Genetic Engineering 8
- RNA and protein synthesis mechanisms 5
- RNA modifications and cancer 4
- Advanced biosensing and bioanalysis techniques 4
- RNA regulation and disease 3
- RNA Research and Splicing 3
- Pluripotent Stem Cells Research 1
Genetics top 2%
Insect Science top 2%
Public Health, Environmental and Occupational Health
- Mosquito-borne diseases and control 2

Co-authors: Shengdar Q. Tsai J. Keith Joung Nathalie T. Nguyen Martin J. Aryee Zongli Zheng Michelle S. Prew Benjamin P. Kleinstiver Cyd Khayter
Cited by: Business and International Management Aging Molecular Biology
Journals: Nature (1 paper)Journal of the American Chemical Society (1 paper)Nature Biotechnology (3 papers)
Partner nations: United States Hong Kong Sweden

In The Last Decade

Ved V. Topkar

15 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Ved V. Topkar

Since Specialization

Citations

This map shows the geographic impact of Ved V. Topkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ved V. Topkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ved V. Topkar more than expected).

Fields of papers citing papers by Ved V. Topkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ved V. Topkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ved V. Topkar. The network helps show where Ved V. Topkar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ved V. Topkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ved V. Topkar Line = papers co-authored together Ved V. Topkar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Three-dimensional structure-guided evolution of a ribosome with tethered subunits Nature Chemical Biology ·Do Soon Kim,Andrew M. Watkins,Erik J. Bidstrup,Joongoo Lee,Ved V. Topkar,Camila Kofman,Kevin J. Schwarz,Yan Liu,Grigore Pintilie,Emily Roney,Rhiju Das,Michael C. Jewett	2022	13
2	Defining genome-wide CRISPR–Cas genome-editing nuclease activity with GUIDE-seq Nature Protocols ·Nikolay Malinin,GaHyun Lee,Cícera R. Lazzarotto,Yichao Li,Zongli Zheng,Nathalie T. Nguyen,Matthew Liebers,Ved V. Topkar,A. John Iafrate,Long P. Le,Martin J. Aryee,J. Keith Joung,Shengdar Q. Tsai	2021	46
3	mRNA Transport and Local Translation in Glia Trends in Cell Biology ·Lindsey M. Meservey,Ved V. Topkar,Meng‐meng Fu	2021	14
4	Accelerated cryo-EM-guided determination of three-dimensional RNA-only structures Nature Methods ·Kalli Kappel,Kaiming Zhang,Zhaoming Su,Andrew M. Watkins,Wipapat Kladwang,Shanshan Li,Grigore Pintilie,Ved V. Topkar,Ramya Rangan,Ivan N. Zheludev,Joseph D. Yesselman,Wah Chiu,Rhiju Das	2020	120
5	Anomalous Reverse Transcription through Chemical Modifications in Polyadenosine Stretches Biochemistry ·Wipapat Kladwang,Ved V. Topkar,Bei Liu,Ramya Rangan,Tracy L. Hodges,Sarah C. Keane,Hashim M. Al‐Hashimi,Rhiju Das	2020	8
6	Transcription factors, coregulators, and epigenetic marks are linearly correlated and highly redundant PLoS ONE ·Tobias Ahsendorf,Frank Müller,Ved V. Topkar,Jeremy Gunawardena,Roland Eils	2017	6
7	CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targetsbreakdown → Nature Methods ·Shengdar Q. Tsai,Nathalie T. Nguyen,Jose Malagon-Lopez,Ved V. Topkar,Martin J. Aryee,J. Keith Joung	2017	547
8	Circularization for In vitro Reporting of Cleavage Effects (CIRCLE-seq) Protocol Exchange ·Ashleigh Carver,Shengdar Q. Tsai,Nathalie T. Nguyen,Jose Malagon-Lopez,Ved V. Topkar,Martin J. Aryee,J. Keith Joung	2017	1
9	Open-source guideseq software for analysis of GUIDE-seq data Nature Biotechnology ·Shengdar Q. Tsai,Ved V. Topkar,J. Keith Joung,Martin J. Aryee	2016	49
10	Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognitionbreakdown → Nature Biotechnology ·Benjamin P. Kleinstiver,Michelle S. Prew,Shengdar Q. Tsai,Nathalie T. Nguyen,Ved V. Topkar,Zongli Zheng,J. Keith Joung	2015	466
11	Engineered CRISPR-Cas9 nucleases with altered PAM specificitiesbreakdown → Nature ·Benjamin P. Kleinstiver,Michelle S. Prew,Shengdar Q. Tsai,Ved V. Topkar,Nathalie T. Nguyen,Zongli Zheng,Andrew P. W. Gonzales,Zhuyun Li,Randall T. Peterson,Jing-Ruey Joanna Yeh,Martin J. Aryee,J. Keith Joung	2015	1256
12	58. Engineered Cas9 Variants with Novel PAM Specificities Expand the Targeting Range of CRISPR/Cas Nucleases Molecular Therapy ·Benjamin P. Kleinstiver,Michelle S. Prew,Ved V. Topkar,Shengdar Q. Tsai,Jae K. Joung	2015	2
13	Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing Human Gene Therapy ·Nicolas Wyvekens,Ved V. Topkar,Cyd Khayter,J. Keith Joung,Shengdar Q. Tsai	2015	121
14	Replacing Uridine with 2-Thiouridine Enhances the Rate and Fidelity of Nonenzymatic RNA Primer Extension Journal of the American Chemical Society ·Benjamin D. Heuberger,Ayan Pal,Francesca Del Frate,Ved V. Topkar,Jack W. Szostak	2015	62
15	GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleasesbreakdown → Nature Biotechnology ·Shengdar Q. Tsai,Zongli Zheng,Nathalie T. Nguyen,Matthew Liebers,Ved V. Topkar,Vishal Thapar,Nicolas Wyvekens,Cyd Khayter,A. John Iafrate,Long P. Le,Martin J. Aryee,J. Keith Joung	2014	1582

About Ved V. Topkar

Ved V. Topkar is a scholar working on Structural Biology, Business and International Management and Molecular Biology, having authored 15 papers that have together received 4.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), RNA and protein synthesis mechanisms (5 papers), RNA modifications and cancer (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA regulation and disease (3 papers), RNA Research and Splicing (3 papers), Mosquito-borne diseases and control (2 papers) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Business and International Management (542 citations), Aging (358 citations) and Molecular Biology (4.2k citations). Ved V. Topkar has collaborated with scholars based in United States, Hong Kong and Sweden. Frequent co-authors include Shengdar Q. Tsai, J. Keith Joung, Nathalie T. Nguyen, Martin J. Aryee, Zongli Zheng, Michelle S. Prew, Benjamin P. Kleinstiver, Cyd Khayter, Nicolas Wyvekens and A. John Iafrate. Their work appears in journals such as Nature, Journal of the American Chemical Society and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact